Dr. Amin M. Abyad Specialist Medical Oncology & Internal Medicine

Awards & Achievements

• Hematology and Oncology Fellowship
• Research scholarship from Arab Medical Association Against Cancer (AMAAC) to attend the annual research summer school at King Abdullah International Medical Research Center (KAIMRC). Riyadh- Kingdom Of Saudi Arabia
• Nominated as the most promising junior Arab researcher over the research project entitled: “The Efficacy of prolonged Timozolamide in Glioblastoma Multiforme”
• Makassed Hospital research oof the year award: Infectious complications after allogeneic BMT- Our experience over the last decade
• Awarded fellow of the year by the Department Of Internal Medicine

Research & Publications

• Co-author: “The Efficacy of prolonged Timozolamide in Glioblastoma Multiforme” M. ElNaghy et al poster presentation European Society Of Medical Oncology (ESMO) conference “Trends in Central Nervous System Malignancies” held In Prague- Czech Republic and poster presentation at Lebanese Society Of Medical Oncology (LSMO) 11th National Forum April 2014
• Co-author: Healthcare Workers’ Compliance to the “Five Moments for Hand Hygiene” Comparison Of Two Interventional Methods. This study was published as a poster in IDSA conference on Oct 2016
• Co-author: Low toxicity and efficacy of high-dose chemotherapy TEAM (Thiotepa, Ttoposide, Aracytine, Melphalan) followed by autologous peripheral blood stem cell transplantation in lymphoma. Oral presentation at EBMT 2019
• Co-author: Performance Evaluation of the Spectra Optia Apheresis System Mononuclear Cell Collection for Autologous Peripheral Stem Cell Transplantation. Poster presentation EBMT 2019
• Co-author: bacteraemia post-autologous hematopoietic stem cell transplantation in the absence of antibacterial prophylaxis: a decade's experience from Lebanon. Poster presentation EBMT 2020
• Co-author: High dose chemotherapy team (theotepa, etoposide, aracytine, melphalan) followed by autologous peripheral blood stem cell transplantation in lymphoma. Preliminary results of a prospective study. Poster presentation EBMT 2020
• Co-author: Pre‑engraftment infectious complications and patient outcomes after allogeneic hematopoietic cell transplantation: a single‑center experience from Lebanon Springer-Verlag GmbH Germany, part of Springer Nature 2020 https://doi.org/10.1007/s15010-020-01407-6
• Co-author: The Burden of Gynecologic Cancers in the UAE, H. Alshamsi et al, J Oncol Res Rev Rep 2021 Volume 2(4): 2-6
• Co-author: Establishment of the First Comprehensive Adult and Pediatric Hematopoietic Stem Cell Transplant Unit in the United Arab Emirates: Rising to the Challenge, Humaid Alshamsi et al. Clin. Pract. 2022, 12(1), 84-90; https://doi.org/10.3390/clinpract12010010
• Co-author: A Proposal for a National Cancer Control Plan for the UAE: 2022–2026 Humaid O. Al-Shamsi 1,2,3,4,* , Amin M. Abyad 1,2,4 and Saeed Raf Clin. Pract. 2022, 12, 118–132. https://doi.org/10.3390/ clinpract12010016
• Co-author: Breast Cancer in the United Arab Emirates Humaid O. Al-Shamsi et al, JCO Global Oncol DOI https://doi. org/10.1200/GO.22. 00247

Education & Training

• MBChB
• Internal Medicine Residency

Membership

• ESMO
• Emirates Oncology Society